Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

·24 Aug
Share:PostShare

BOSTON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that management will participate in one-on-one meetings at the upcoming Wells Fargo 21 st Annual Healthcare Conference, taking place September 8-10, 2026, in Boston, MA.

G

Globe Newswire

Original source

Read full story

wells fargo

Check live status on DownRightNow

Check status →

Related Stories

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer